<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Algorithms - PiCCO Online Manual</title>
    <link href="https://fonts.googleapis.com/css2?family=Lato:wght@400;700&family=Montserrat:wght@40;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../CSS/main.css">
    <link rel="stylesheet" href="../CSS/print.css" media="print">
</head>
<body>
    <div class="nav-overlay" id="nav-overlay"></div>
    <header class="main-header">
        <h1 class="site-title"><a href="../index.html" class="site-title">PiCCO - Online Manual</a></h1>
        <button class="menu-toggle" id="menu-toggle">&#9776;</button>
    </header>

    <div class="wrapper container">
        <nav class="main-nav" id="main-nav">
            <h2>Sections</h2>
            <div class="search-container">
                <input type="text" id="searchInput" placeholder="Search sections..." aria-label="Search sections">
            </div>
            <ul>
                <li><a href="introduction.html">Introduction</a></li>
                <li><a href="principles.html">Principles</a></li>
                <li><a href="history.html">History</a></li>
                <li><a href="equipment.html">Equipment</a></li>
                <li><a href="calibration.html">Calibration</a></li>
                <li><a href="indications.html">Indications</a></li>
                <li><a href="contraindications.html">Contraindications</a></li>
                <li><a href="limitations.html">Limitations</a></li>
                <li><a href="pediatric.html">Pediatric considerations</a></li>
                <li><a href="preload.html">Preload</a></li>
                <li><a href="contractility.html">Contractility</a></li>
                <li><a href="lungwater.html">Lung water</a></li>
                <li><a href="afterload.html">Afterload</a></li>
                <li><a href="dynamic.html">Dynamic parameters</a></li>
                <li><a href="derived.html">Derived parameters</a></li>
                <li><a href="algorithms.html">Algorithms</a></li>
                <li><a href="cases.html">Clinical cases</a></li>
                <li><a href="errors.html">Errors</a></li>
                <li><a href="physiology.html">Physiology</a></li>
                <li><a href="reference.html">Reference</a></li>
                <li><a href="faq.html">FAQ</a></li>
                <li><a href="visualizations.html">Visualizations</a></li>
                <li><a href="about.html">About</a></li>
                <li><a href="simulation.html">Quiz</a></li>
            </ul>
        </nav>

        <main class="main-content">
            <h2>PiCCO Algorithms: Key Decision-Making Schemes</h2>
            <p>PiCCO algorithms provide a structured approach to identifying the specific physiological defect limiting oxygen delivery (DO2) and guide targeted therapy (fluids, inotropes or vasopressors), while minimizing the risk of pulmonary edema (EVLWI).</p>

            <div class="info-box info-box-info">
                <h3>Hemodynamic Optimization Algorithm</h3>
                <p>The goal of this algorithm is to maintain <strong>oxygen delivery (DO2)</strong> above metabolic needs, sequentially optimizing preload, afterload and contractility, with strict control of pulmonary edema risk (EVLWI).</p>

                <h4>Step 1: Status Check and Goal Setting</h4>
                <p>Before any intervention, confirm the patient's current status and required goals.</p>
                <ul>
                    <li><strong>Flow and Power:</strong> Check <strong>Cardiac Index (CI)</strong> (Goal ‚â• 2.5) and <strong>Cardiac Power Index (CPI)</strong> (Goal ‚â• 0.5)</li>
                    <li><strong>Perfusion:</strong> Check <strong>MAP</strong> (Goal ‚â• 65 mmHg) and clinical markers (lactate, diuresis)</li>
                    <li><strong>Safety Check:</strong> Check <strong>Extravascular Lung Water Index (EVLWI)</strong> (Goal ‚â§ 10 ml/kg). If EVLWI is critically high (>15), prioritize fluid restriction/removal</li>
                </ul>

                <h4>Step 2: Volume/Preload Optimization (Fluid Decision)</h4>
                <p>Give priority to dynamic indices. Only give fluid if the patient has proven responsiveness and the lungs are in relative safety.</p>
                
                <table class="scenario-table">
                    <thead>
                        <tr>
                            <th>Assessment</th>
                            <th>PiCCO Guidance</th>
                            <th>Therapeutic Action</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Responsiveness</strong></td>
                            <td><strong>SVV/PPV > 10%, OR Œîresp CO ‚â• 5%</strong></td>
                            <td><strong>Fluid Challenge</strong> (e.g., 250 ml colloid). Monitor for CI increase and EVLWI safety</td>
                        </tr>
                        <tr>
                            <td><strong>Endpoint</strong></td>
                            <td><strong>SVV ‚â§ 10% AND CI is adequate</strong></td>
                            <td><strong>Stop Fluid.</strong> Proceed to Step 3</td>
                        </tr>
                        <tr>
                            <td><strong>Volume Overload</strong></td>
                            <td><strong>GEDVI > 800 ml/m¬≤ OR EVLWI > 10 ml/kg</strong></td>
                            <td><strong>Fluid Restriction / Removal</strong> (diuretics/RRT). Reverse fluids where possible</td>
                        </tr>
                    </tbody>
                </table>

                <h4>Step 3: Afterload/Resistance Optimization (Vasoactive Decision)</h4>
                <p>Address pressure-flow issues using SVRI.</p>
                
                <table class="scenario-table">
                    <thead>
                        <tr>
                            <th>Assessment</th>
                            <th>PiCCO Guidance</th>
                            <th>Therapeutic Action</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Vasodilation/Hypotension</strong></td>
                            <td><strong>SVRI < 1700 AND MAP below goal</strong></td>
                            <td><strong>Vasopressors</strong> (e.g., norepinephrine) to increase SVRI to <strong>1700-2500</strong></td>
                        </tr>
                        <tr>
                            <td><strong>Excessive Resistance</strong></td>
                            <td><strong>SVRI > 2500 AND CI is low</strong></td>
                            <td><strong>Vasodilators</strong> (if MAP allows) to reduce resistance and improve flow</td>
                        </tr>
                    </tbody>
                </table>

                <h4>Step 4: Contractility/Pump Function Optimization (Inotropic Decision)</h4>
                <p>If CI is still inadequate after optimizing preload and afterload, the problem is the myocardium.</p>
                
                <table class="scenario-table">
                    <thead>
                        <tr>
                            <th>Assessment</th>
                            <th>PiCCO Guidance</th>
                            <th>Therapeutic Action</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Pump Failure</strong></td>
                            <td><strong>CFI < 4.5 OR GEF < 25%</strong> (after GEDVI is optimal)</td>
                            <td><strong>Inotropic Support</strong> (e.g., dobutamine) to increase CFI and CI</td>
                        </tr>
                        <tr>
                            <td><strong>High Target CI</strong></td>
                            <td>If high VO2 requires CI ‚â• 4.0 (e.g., hyperdynamic sepsis)</td>
                            <td>Use inotropes to achieve high CI target</td>
                        </tr>
                    </tbody>
                </table>

                <h4>Step 5: Final Check and Endpoint (Oxygen Transport)</h4>
                <p>Confirm that all interventions have reached the goal of maintaining hemodynamic stability.</p>
                <ul>
                    <li><strong>Oxygen Delivery Check:</strong> Calculate <strong>DO2I</strong>. If low (<450), re-evaluate all components (CI, Hgb, SaO2)</li>
                    <li><strong>Oxygen Consumption Check:</strong> Calculate <strong>O2ER</strong>. If high (>30%), tissues are struggling; DO2I must be aggressively increased</li>
                </ul>

                <p>The optimization process is cyclical. After completing Step 4, return to Step 1 to reassess the patient's status and continue the cycle until achieving hemodynamic stability and maintenance.</p>
            </div>

            <div class="info-box info-box-warning">
                <h3>Shock Phenotyping Algorithm</h3>
                <p>The goal is to differentiate between the main types of shock - <strong>hypovolemic, cardiogenic and distributive</strong> - by sequentially assessing flow, volume and resistance.</p>

                <h4>Step 1: Initial Flow Assessment (Cardiac Index - CI)</h4>
                <p>The algorithm starts with assessing systemic flow (DO2) adequacy.</p>
                
                <table class="scenario-table">
                    <thead>
                        <tr>
                            <th>CI Range (L/min/m¬≤)</th>
                            <th>Interpretation</th>
                            <th>Next Step</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Low (<3.0)</strong></td>
                            <td><strong>Flow impaired.</strong> Could be hypovolemic or cardiogenic</td>
                            <td>Proceed to <strong>Step 2</strong> for volume status assessment</td>
                        </tr>
                        <tr>
                            <td><strong>High/Normal (‚â•3.0)</strong></td>
                            <td><strong>Flow adequate or excessive.</strong> Suggests distributive shock (or obstructive/compensated)</td>
                            <td>Proceed to <strong>Step 4</strong> for resistance assessment</td>
                        </tr>
                    </tbody>
                </table>

                <h4>Step 2: If Flow is Low (CI < 3.0), Assess Preload Status</h4>
                <p>We use dynamic and static parameters to determine if the low flow is caused by volume insufficiency.</p>
                
                <table class="scenario-table">
                    <thead>
                        <tr>
                            <th>Parameter</th>
                            <th>Threshold</th>
                            <th>Diagnosis/Action</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>SVV or PPV</strong></td>
                            <td><strong>High (>10-13%)</strong></td>
                            <td><strong>Responds to Fluid.</strong> Indicates volume dependency</td>
                        </tr>
                        <tr>
                            <td><strong>GEDVI</strong></td>
                            <td><strong>Low (<680 ml/m¬≤)</strong></td>
                            <td><strong>Hypovolemic Shock (confirmed).</strong></td>
                            <td><strong>Therapy:</strong> <strong>Fluid Therapy</strong></td>
                        </tr>
                        <tr>
                            <td><strong>SVV or PPV</strong></td>
                            <td><strong>Low (<10-13%)</strong></td>
                            <td><strong>Does Not Respond to Fluid.</strong> Volume status is adequate</td>
                        </tr>
                        <tr>
                            <td><strong>GEDVI</strong></td>
                            <td><strong>Optimal/High (‚â•680 ml/m¬≤)</strong></td>
                            <td>Not hypovolemic. Proceed to <strong>Step 3</strong></td>
                        </tr>
                    </tbody>
                </table>

                <h4>Step 3: If Flow is Low and Preload is Optimal, Assess Contractility</h4>
                <p>With adequate volume, low flow should be associated with pump failure.</p>
                
                <table class="scenario-table">
                    <thead>
                        <tr>
                            <th>Parameter</th>
                            <th>Threshold</th>
                            <th>Diagnosis/Action</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>CFI or GEF</strong></td>
                            <td><strong>Low (CFI < 4.5 or GEF < 25%)</strong></td>
                            <td><strong>Cardiogenic Shock (confirmed).</strong> Internal pump failure</td>
                            <td><strong>Therapy:</strong> <strong>Inotropic Support</strong> (e.g., dobutamine). Check EVLWI and add diuretics if needed</td>
                        </tr>
                        <tr>
                            <td><strong>CFI or GEF</strong></td>
                            <td><strong>Normal/High</strong></td>
                            <td>Low flow may be associated with severe uncompensated high afterload</td>
                        </tr>
                    </tbody>
                </table>

                <h4>Step 4: If Flow is High (CI ‚â• 3.0), Assess Afterload/Resistance</h4>
                <p>High or normal flow with shock symptoms (e.g., hypotension, lactate) indicates vasodilation and improper distribution.</p>
                
                <table class="scenario-table">
                    <thead>
                        <tr>
                            <th>Parameter</th>
                            <th>Threshold</th>
                            <th>Diagnosis/Action</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>SVRI</strong></td>
                            <td><strong>Low (<1700 dyn¬∑s¬∑cm‚Åª‚Åµ¬∑m¬≤)</strong></td>
                            <td><strong>Distributive Shock (confirmed).</strong> Pathological vasodilation (e.g., sepsis)</td>
                            <td><strong>Therapy:</strong> <strong>Vasopressors</strong> (e.g., norepinephrine) to increase SVRI and maintain MAP</td>
                        </tr>
                        <tr>
                            <td><strong>SVRI</strong></td>
                            <td><strong>High (>2500)</strong></td>
                            <td><strong>Obstructive/Compensated Shock.</strong> Flow is high, but resistance is also high, or the problem is in flow distribution</td>
                        </tr>
                    </tbody>
                </table>

                <h4>Summary Table: Shock Profiles and Therapeutic Focus</h4>
                <table class="scenario-table">
                    <thead>
                        <tr>
                            <th>Shock Type</th>
                            <th>CI (Flow)</th>
                            <th>GEDVI (Preload)</th>
                            <th>SVRI (Afterload)</th>
                            <th>EVLWI (Safety)</th>
                            <th>Primary Therapeutic Focus</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Hypovolemic</strong></td>
                            <td>Low</td>
                            <td><strong>Low</strong></td>
                            <td>High</td>
                            <td>Low</td>
                            <td><strong>FLUID</strong> (volume replacement)</td>
                        </tr>
                        <tr>
                            <td><strong>Cardiogenic</strong></td>
                            <td>Low</td>
                            <td>Optimal/High</td>
                            <td>High</td>
                            <td><strong>High</strong></td>
                            <td><strong>INOTROPES</strong> (pump support)</td>
                        </tr>
                        <tr>
                            <td><strong>Distributive (sepsis)</strong></td>
                            <td>High/Normal</td>
                            <td>Low/Normal</td>
                            <td><strong>Low</strong></td>
                            <td>Often High</td>
                            <td><strong>VASOPRESSORS</strong> (vascular tone)</td>
                        </tr>
                    </tbody>
                </table>
            </div>

            <div class="info-box info-box-success">
                <h3>Step-by-Step TPTD Calibration Guide</h3>
                <p>Calibration is an important intermittent process that links continuous hemodynamic monitoring data (pulse contour analysis, PCA) with precise, absolute volumetric and flow values obtained from transpulmonary thermodilution (TPTD).</p>
                
                <ol>
                    <li><strong>System Readiness Check (Before Injection)</strong>
                        <ul>
                            <li>Ensure the patient is in a stable clinical state (or at least stable for the 60-second measurement window)</li>
                            <li>Check that the syringe contains the correct volume of cold NaCl (10-20 mL). Critically important that <strong>all air bubbles are carefully removed</strong>, as air seriously compromises the accuracy of the thermal signal</li>
                            <li>On the monitor, ensure the displayed <strong>injectate temperature (T_inj)</strong> is stable and low (ideally ‚â§ 8¬∞C). The system often uses this measurement in its quality checks</li>
                            <li>Check the arterial line: ensure the arterial pressure waveform is stable, properly damped, and free from artifacts</li>
                        </ul>
                    </li>
                    
                    <li><strong>Measurement Activation</strong>
                        <ul>
                            <li>Select the appropriate function on the monitor (e.g., "Start TPTD", "Calibrate", or "CO")</li>
                            <li>The monitor typically displays a prompt confirming readiness. Prepare for rapid injection based on the system's audio cue or countdown</li>
                        </ul>
                    </li>
                    
                    <li><strong>Indicator Injection (Key Action)</strong>
                        <ul>
                            <li>Inject the entire volume of cold indicator (10-20 mL) <strong>as rapidly and smoothly as possible</strong> (ideally within 5-10 seconds)</li>
                            <li><strong>Rationale:</strong> Rapid injection ensures the thermal signal is introduced into the central circulation as a compact bolus, maximizing signal-to-noise ratio and ensuring a reproducible thermal curve. A slow injection will smear the curve, leading to underestimation of CO</li>
                        </ul>
                    </li>
                    
                    <li><strong>Thermodilution Curve Analysis</strong>
                        <ul>
                            <li>The monitor automatically displays the TPTD curve - a plot of temperature versus time recorded by the arterial thermistor</li>
                            <li>The system software instantly analyzes the curve:
                                <ul>
                                    <li><strong>Area under the curve:</strong> used to calculate measured CO_TPTD</li>
                                    <li><strong>Mean transit time (MTt):</strong> used to calculate GEDV and ITBV</li>
                                    <li><strong>Exponential downslope time (DSt):</strong> used to calculate EVLW</li>
                                </ul>
                            </li>
                        </ul>
                    </li>
                    
                    <li><strong>Quality Control and Averaging</strong>
                        <ul>
                            <li><strong>Curve Assessment:</strong> The monitor has internal quality checks and may reject a curve if the injection was too slow, if there were pressure artifacts (e.g., patient movement) or if T_inj was unstable</li>
                            <li><strong>Repeat Measurements:</strong> To ensure statistical reliability and clinical accuracy, <strong>at least 3 consecutive, accepted TPTD measurements</strong> must be performed</li>
                            <li><strong>Averaging:</strong> The system automatically averages the accepted CO values (and correspondingly GEDV and EVLW values). The difference between the accepted CO values should typically be within 10% for the measurement set to be considered valid</li>
                        </ul>
                    </li>
                    
                    <li><strong>Completion and Continuous Monitoring</strong>
                        <ul>
                            <li><strong>Acceptance:</strong> Confirm the averaged, validated values on the monitor (e.g., "Accept Values")</li>
                            <li><strong>PCA Recalibration:</strong> The system uses the newly confirmed, accurate measured CO_TPTD values to <strong>recalculate and update the calibration factor K</strong> for the pulse contour analysis PCA algorithm</li>
                            <li><strong>Return to Continuous Mode:</strong> The system automatically returns to displaying continuous, calibrated parameters (PCCO, SVV, PPV) that are now synchronized with the patient's current hemodynamic status</li>
                        </ul>
                    </li>
                </ol>
            </div>

            <div class="info-box info-box-danger">
                <h3>Rules for Recalibration (When to Repeat TPTD)</h3>
                <p>To prevent "drift" of the PCA coefficient, recalibration is mandatory under the following clinical conditions:</p>
                <ol>
                    <li><strong>Scheduled intervals:</strong> Regularly every <strong>6-8 hours</strong>, or according to institutional protocol</li>
                    <li><strong>Vasopressor/inotrope changes:</strong> After any significant initiation, cessation, or major titration (e.g., dose change >20%) of <strong>vasoactive drugs</strong> (e.g., norepinephrine, vasopressin) or <strong>inotropes</strong> (e.g., dobutamine). These drugs fundamentally change arterial compliance and vascular tone, making the old calibration factor K invalid</li>
                    <li><strong>Significant volume shifts:</strong> After rapid infusion of large volume fluid (e.g., ‚â•500 mL crystalloid), significant blood loss, or initiation of renal replacement therapy (RRT) involving major volume removal</li>
                    <li><strong>Clinical data mismatch:</strong> If the continuous PCCO or CI displayed on the monitor does not match the patient's clinical state (e.g., patient appears deeply shocked but CI shows normal)</li>
                </ol>
            </div>

            <div class="info-box info-box-warning">
                <h3>Common Calibration Errors</h3>
                <p>The accuracy of the PiCCO method relies heavily on a clean, reproducible TPTD curve. Errors introduced during the cold saline injection process or due to technical issues can lead to significant errors in CO, volume (GEDV), and lung water (EVLW) measurements.</p>
                
                <h4>Injection and Technique Errors</h4>
                <ul>
                    <li><strong>Slow or hesitant injection:</strong> Injecting the bolus slowly (over 15-20 seconds) rather than rapidly (‚â§10 seconds) stretches and delays the thermal signal. The area under the curve (CO) is preserved, but the mean transit time (MTt) is artificially prolonged, leading to falsely high GEDVI and ITBVI values</li>
                    <li><strong>Air injection:</strong> Failure to completely remove air bubbles from the syringe or injection line. Air acts as a thermal insulator and prematurely dissipates the cold signal in the right heart/pulmonary artery, leading to falsely low CO</li>
                    <li><strong>Warm injectate solution:</strong> Using solution that is too warm (e.g., room temperature) or not using external cooling. Insufficient temperature difference (ŒîT) between blood and injectate. The resulting curve is small and noisy, leading to unreliable CO measurement</li>
                    <li><strong>Inconsistent bolus volume:</strong> Changing the volume of injectate between the 3 required measurements (e.g., 15 mL, then 10 mL, then 15 mL). Direct calculation error, as the injectate volume (V_inj) is a fixed variable in the Stewart-Hamilton equation, leading to high variability (non-reproducibility) in CO measurements</li>
                </ul>
            </div>

            <div class="info-box info-box-info">
                <h3>Algorithm for Differentiating Pulmonary Edema Causes</h3>
                <p>Using EVLWI and PVPI to differentiate between hydrostatic and permeability pulmonary edema.</p>
                
                <h4>Step 1: Assess EVLWI</h4>
                <p>Check the Extravascular Lung Water Index to determine if pulmonary edema is present.</p>
                
                <table class="scenario-table">
                    <thead>
                        <tr>
                            <th>EVLWI Range (ml/kg PBW)</th>
                            <th>Clinical Interpretation</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Normal</strong></td>
                            <td><strong>3.0 - 7.0</strong></td>
                        </tr>
                        <tr>
                            <td><strong>Mild Edema</strong></td>
                            <td><strong>7.0 - 10.0</strong></td>
                        </tr>
                        <tr>
                            <td><strong>Moderate Edema</strong></td>
                            <td><strong>10.0 - 15.0</strong></td>
                        </tr>
                        <tr>
                            <td><strong>Severe Edema</strong></td>
                            <td><strong>>15.0</strong></td>
                        </tr>
                    </tbody>
                </table>

                <h4>Step 2: Calculate and Assess PVPI</h4>
                <p>Calculate PVPI = EVLWI / ITBVI to determine the cause of pulmonary edema.</p>
                
                <table class="scenario-table">
                    <thead>
                        <tr>
                            <th>PVPI Range</th>
                            <th>Clinical Interpretation</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Optimal</strong></td>
                            <td><strong>1.0 - 1.7</strong></td>
                        </tr>
                        <tr>
                            <td><strong>High</strong></td>
                            <td><strong>>1.7</strong></td>
                        </tr>
                    </tbody>
                </table>

                <h4>Step 3: Determine Edema Type and Therapy</h4>
                <table class="scenario-table">
                    <thead>
                        <tr>
                            <th>Condition</th>
                            <th>EVLWI</th>
                            <th>ITBVI</th>
                            <th>Expected PVPI</th>
                            <th>Primary Mechanism</th>
                            <th>Therapy Approach</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Cardiogenic Edema</strong></td>
                            <td>Often High</td>
                            <td>High</td>
                            <td><strong>Normal (‚â§ 1.7)</strong></td>
                            <td>Increased hydrostatic pressure due to heart failure (High ITBVI)</td>
                            <td><strong>Diuretics</strong> to reduce preload and hydrostatic pressure</td>
                        </tr>
                        <tr>
                            <td><strong>ARDS / Capillary Leak</strong></td>
                            <td>Often High</td>
                            <td>Normal or Low</td>
                            <td><strong>High (>1.7)</strong></td>
                            <td>Capillary permeability damage allows protein-rich fluid to leak out (High EVLWI relative to ITBVI)</td>
                            <td><strong>Fluid restriction</strong> and supportive care for permeability issue</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </main>
    </div>

    <footer class="main-footer">
        <div class="container">
            <p>&copy; 2025 PiCCO Online Manual</p>
        </div>
    </footer>
    <button class="theme-switcher" id="theme-switcher" aria-label="Toggle theme">
        <span class="icon-sun">‚òÄÔ∏è</span>
        <span class="icon-moon" style="display: none;">üåô</span>
    </button>
    <script src="../JS/search.js"></script>
    <script src="../JS/main.js"></script>
</body>
</html>





